How do these numbers compare with the same couple of months (December/January) of 2014? Meaning, was there a similar leveling off around the end/beginning of the year in 2014, but that numbers started ticking up over the course of the year. I was hoping to get to 12,500 by the end of Q1, but I'm not so sure now - unless they can make some hay out of the inferiority of the GL.
So, I wonder if they're in for Reduce-It interim or full on until the shoe drops. Would love to know what their due diligence says.
Contrast JT's comments about the success of R-IT to his comments about the "uphill battle" with the FDA on Anchor. I would think that with the lessons learned about overly confident statements (read JZ's "not a penny less than $30" and "the next 60-90 days are going to be exciting") that he is very measured, especially since he comes by it naturally as a bean counter, in his statements about the company in general and R-IT, specifically.
Hit the flag button and an option to ignore will pop up. I have him on ignore and it's pretty clear what he does when he's not asleep!
It is becoming clearer that the headwinds are trust in the Reduce It trial results and trust in the FDA not to derail the Anchor (or subsequent) approval once Reduce It results are in. Who knows the truth?
Until you threw in the phrase "non existent" I was willing to take your question seriously?
Did you really waste that much of your day cutting and pasting Shortfishfry's posts? Sad.